Bone Marrow (BM) remains a common source for hematopoietic SCT. Due to the transcutaneous approach, contamination with skin bacteria is common. The delay between harvest and transfusion can be considerable, potentially allowing for bacterial proliferation. The optimal transportation temperature, specifically with respect to bacterial growth and consequences thereof for hematopoietic quality, remain undefined. For 72 h, 66 individual BM samples, non-spiked/spiked with different bacteria, stored at 20-24 1C room temperature (RT) or 3-5 1C (cold), were serially analyzed for hematopoietic quality and microbial burden. Under most conditions, hematopoietic quality of BM was equal or better at RT: Typical BM contaminants (P. acnes and S. epidermidis) and E. coli were killed or bacterial proliferation was arrested at RT; hematopoietic quality was not impacted by the contamination. However, several pathogenic bacteria not typically found in BM (S. aureus and K. pneumoniae) proliferated dramatically at RT and impaired hematopoietic quality. Bacterial proliferation was arrested in the cold. The overwhelming majority of BM samples, that is, those that are sterile or contaminated only with skin commensals, will benefit from transportation at RT. Those bacteria that proliferate and perturb hematopoietic quality are not typically found in BM. Our data support recommendations for RT transportation and storage of BM.
INTRODUCTION
BM cells, transcutaneously aspirated under general anesthesia from the posterior iliac crest, remain the stem cell source for approximately 20% of allogeneic transplantations. [1] [2] [3] Reasons for the preference of BM over mobilized peripheral blood may lie on the donor side, such as exclusion criteria for stimulation with granulocyte colony-simulating factor or personal preference for BM donation, as well as on the patient side, for instance with the intention to reduce the risk of chronic GVHD in recipients with non-malignant illness. [4] [5] [6] Even though the technique of BM harvesting has been practiced for more than 40 years, 7 the technology has not evolved significantly. The transcutaneous access and repeated passing of the collection needle through the punctured skin during collection inevitably expose the BM to the risk of bacterial contamination. 8 Indeed, BM harvesting is associated with a 5-15% rate of bacterial contamination, [8] [9] [10] [11] [12] [13] [14] almost exclusively with skin commensals belonging to the resident skin flora and dwelling in deep layers of the epidermis and specifically in hair follicles. With rare exceptions, the contaminants are nonpathogenic for immuno-competent patients, typically anaerobic or microaerophilic bacteria from the physiological skin flora. 9 Accordingly, harm to SCT recipients from contaminated stem cell products in general and contaminated BM products in particular has been reported very infrequently. [15] [16] [17] [18] [19] Historical data, albeit not unrefuted by later studies, suggest that BM should best be transported at room temperature (RT), 20, 21 and indeed this is the recommendation of the NMDP. 22 However, in BM aspirates that are bacterially contaminated, RT storage could allow for significant bacterial proliferation while many pathogens arrest in growth at low temperatures.
Resulting large numbers of bacteria in the BM aspirate could in turn either endanger the recipient directly by inducing sepsis or endogenous shock syndrome or could jeopardize the hematopoietic quality of the BM cells and thus indirectly harm the patient. Apparently in view of this hypothesis, but without seeking formal evidence to support it, the German federal agency has requested storage at 4 1C for all BM products which will not be infused within 24 h of the harvest end, and in the 'PBSC vs marrow' of the NMDP study all marrows were kept at 4 1C.
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In contrast, NMDP, ZKRD and WMDA recommend transportation of BM at RT, irrespective of the transportation time. 20, 22, [23] [24] [25] An alternative scenario, phagocytosis of contaminating bacteria by BM leukocytes and thus de-contamination, can also be entertained; for this to happen, at least transient roomtemperature storage would be required. The ability of whole blood to 'autosterilize' is routinely exploited; thus, whole blood must be stored at RT for several hours before it may be cooled or component separation can commence. In order to provide guidance about optimal storage temperatures of bacterially contaminated BM cells, we systematically analyzed microbiological and hematopoietic quality of BM samples inoculated with known quantities of defined bacteria. We also sought to reproduce and extend observations pre-dating the advent of multi-parametric CD34 þ cell enumeration and in vitro colony assays, some of which had suggested a favourable haematological quality of BM stored at RT compared to 4 1C.
MATERIALS AND METHODS

Primary BM aspirates
BM was collected for matched-unrelated transplantation from normal healthy volunteer BM donors. From products which contained a marked excess of BM cells relative to the requested dose, an aliquot of 8 mL of BM (7 mL for studies with low bacterial concentrations) was removed for our analyses using a small blood bag and sterile tube welding device. 66 samples were thus collected between March and June, 2012. Samples were used within 4 h of the end of the marrow collection, until which they were stored at 4 ± 1 1C. Samples were anonymized. The study was performed with written informed consent from the donors and permission from the local IRB (permit #47/12).
Study procedure BM suspension was transferred to 14-mL conical tubes (Falcon tubes; Becton-Dickinson, Heidelberg, Germany). BM aliquots were spiked with indicated colony forming units (CFU) concentrations from the bacterial strains mentioned below or used as unspiked control samples. An aliquot was drawn for bacterial and haematological quality testing (time point 0 h). Then the BM was split into two 14 mL conical tubes, one of which was stored at 4±1 1C (cold-storage), the other at 22±2 1C (room temperature, RT). Aliquots were removed for haematological and bacteriological analysis at the indicated times for up to 72 h after inoculation, 72 h being the shelf life of BM transplants according to German regulations for BM for hematopoietic transplantation (y21a German Medicines Law) and to international standards.
Bacterial strains and spiking experiments
The bacterial strains used were Propionibacterium acnes (verified patient isolate SAM I), Staphylococcus epidermidis (PEI 06-05, Langen, Germany), Escherichia coli (ATCC 35218), Staphylococcus aureus (ATCC 49476) and Klebsiella pneumonia (PEI B 08-07, Langen, Germany). Bacteria were expanded in liquid culture (thioglycolate broth (P. acnes) or nutrient broth 303r (all others); Heipha Dr Mü ller GmbH, Eppelheim, Germany); during log-phase, aliquots were collected and CFU were enumerated using limiting dilution agar plate culture. Approximately 100 CFU/mL or 1 CFU/ mL suspended in NaCl 0.9% in a volume not exceeding 3% of the total sample volume were spiked into BM samples as indicated.
Hematological quality
Fresh or aged BM samples, stored at ambient or cool temperatures as indicated, were subjected to hemocytometry (total leukocytes) by Sysmex XT1800i (Norderstedt, Germany) as well as quantitative flow cytometry for SSC-low, CD45-dim, CD34 þ , 7-AAD-cells (referred to as 'viable CD34 þ cells' or 'CD34 þ /7AAD-cells' throughout the remainder of the manuscript) using the commercial IVD-grade single-platform stem cell enumeration kit on a standard-set-up FACSCalibur flow cytometer (both Becton-Dickinson, Heidelberg, Germany). Analysis was performed with modified ISHAGE gating as described. 26 Myeloid colony-forming activity was assessed as an assay of in vitro stem and progenitor cell function, using commercial cytokine-replete semisolid culture media (MACS HSC-CFU media human complete with Epo, Miltenyi, Bergisch Gladbach, Germany). 27 To prevent bacterial overgrowth, CFU media were supplemented with antibiotics (Pen/Strep 1%, Perbio Science, Bonn, Germany). Aliquots were plated in duplicate and scored for burst-forming unit-erythroid, colony-forming unit-granulocyte, colony-forming unit-macrophage, colony-forming unitgranulocyte/macrophage and multipotent CFU (CFU-GEMM, colonyforming unit-granulocyte/ erythrocyte/ monocytes/ megakaryocyte) after 14 days of culture under standard conditions (37 1C, 5% CO 2 , saturated humidity), using an inverted microscope at 2.5 Â magnification (Olympus CKX41; Olympus, Hamburg, Germany).
Microbiological quality
Aliquots of BM cell suspension were collected at the indicated time points (0-72 h after spiking with bacteria). Part of each aliquot (0.1 mL diluted 1:5 in NaCl 0.9% per bottle for samples with a bioburden of 100 CFU/mL, up to 1.25 mL per bottle for samples spiked with a bioburden of 1 CFU/mL) was inoculated into the EP-conforming commercial liquid culture bottles BacT/ Alert SA/SN (BioMé rieux, Nü rtingen, Germany), incubated in a BacT/Alert 3D 120 incubator at 37 1C, and the time until the color change of the CO 2 indicator was measured as a semiquantitative assay of bacterial content. 28 Positive samples according to BacT/Alert were sent for bacterial identification, to confirm recovery of the spiked agent. The fluorescenceassisted flow cytometry-based Bactiflow assay (AES Chemunex, Combourg, France) was used for direct bacterial enumeration essentially as described; 29 the detection limit was 500 counts/mL. 30, 31 Moreover, limiting dilution agar streak plate assays were performed for quantitative 
RESULTS
Freshly collected BM samples were analyzed at the zero time point (immediately after spiking with bacteria, if applicable), then split, with one aliquot kept at 4 1C (cold), the other at 20-24 1C (RT). Quality was assessed again 24, 48 and 72 h later, that is, each sample was analyzed seven times (3 times for samples spiked with 1 CFU/mL).
Effects of storage temperature on hematopoietic product quality in sterile BM specimen Fourteen independent sterile samples were analyzed. WBC diminished over time, predominantly due to reduction in granulocyte content, more strongly in cold-stored than in roomtemperature stored samples (Figure 1a ; P ¼ 0.098, Po0.001, Po0.001 at 24, 48 and 72 h, respectively). The recovery of CD34 þ /7AAD À (presumably viable CD34 þ ) cells showed a modest linear reduction over time with no apparent differences at RT and 4 1C (Figure 1b) . However, the functional CFU-C assay Quality of BM and storage temperature S Hahn et al indicated that 7AAD negativity significantly overestimates viability of immature hematopoietic cells (recovery of CFU-C being markedly lower than recovery of 'viable CD34 þ cells'). It also demonstrated a modestly less pronounced loss of clonogenic cells stored at RT than in the cold, which, however, failed to reach statistical significance ( Figure 1c , P ¼ 0.18 at 72 h). After 72 h, the end of the shelf life of BM products, 76±4% or 64±8% of CFU-Cs were recovered in RT-or cold-stored BM samples, respectively.
Effects of storage temperature on hematological and microbiological quality of BM samples spiked with bacteria Fresh BM samples were spiked with defined quantities of CFUs of various bacteria as indicated, followed by analysis of hematopoietic quality as well as microbial burden, using quantitative and semi-quantitative assays.
No effect of S. epidermidis inoculation (100 CFU/mL, N ¼ 5 independent samples) on the hematological quality of the BM samples was observed, irrespective of storage temperature (Figures 2a-c) . As in sterile samples, CFU-C recovery was modestly greater at RT (P ¼ 0.01). Bacterial counts remained stable over time at 4 1C, as evidenced both by stable detection times by BacT/Alert and unchanged CFU counts (directly enumerated on blood agar plates) over time (Figures 2d and f) . In contrast, at RT, bacterial phagocytosis was effective: The detection time by BacT/Alert was markedly extended after 48 h, with several bottles already 'sterile', that is, with infinite detection times (Figure 2d) , and all except one sample remained BacT/Alert negative (infinite response time) at the 72 h time point. In agreement with these data, after 72 h the number of CFU was markedly reduced (Figure 2f , P ¼ 0.018, P ¼ 0.003 and P ¼ 0.015 at 24, 48, and 72 h, respectively).
For samples spiked with 100 CFU/mL of P. acnes (N ¼ 6 independent samples, Figure 3 ), CFU numbers on blood agar plates were reduced significantly more strongly in samples stored at RT than at 4 1C (Figure 3f ; P 24 h o0.001, P 48 h ¼ 0.01, P 72 h ¼ 0.01). A corresponding increase in the BacT/Alert response time was not observed, possibly because detection time is more strongly affected by the slow growth kinetics of this bacterium than by comparably modest differences in CFU counts in the inoculum. P. acnes had no adverse effect on hematopoietic product quality (Figures 3a-c) .
A mixed picture emanates from samples inoculated with 100 CFU/mL of E. coli (N ¼ 10 independent samples, Figure 4) . While under 4 1C storage conditions, bacteria were consistently neither phagocytosed nor did they proliferate, at RT, strong proliferation was noted in two samples (by all methods, including Bactiflow), while another two samples auto-sterilized over time. Bacterial counts were grossly unchanged in the remaining six samples. Hematopoietic quality was remarkably well preserved irrespective of bacterial contamination and storage temperature, more so than Figure 3 . Effect of storage temperature in P. acnes-spiked BM samples over time with respect to hematological quality and microbial burden: Panels a-c depict haematological quality of BM products spiked with 100 CFU/mL P. acnes, panels d-f depict microbiological quality (N ¼ 6).
Quality of BM and storage temperature S Hahn et al in any other set of samples. The relative advantage of roomtemperature storage on product quality in E. coli-spiked samples was, at best, modest. Growth of S. aureus (N ¼ 12, Figure 5 ) and K. pneumoniae (N ¼ 7, Figure 6 ) had marked adverse effects on product quality of roomtemperature stored samples: After 72 h of RT storage, significantly fewer CD34 þ /7AAD-cells (P ¼ 0.003) and CFU-C (P ¼ 0.015) were recovered in samples inoculated with S. aureus compared to 4 1C stored samples (Figures 5b and c) . Similarly, in K. pneumoniaespiked samples stored at RT, recovery of CFU-C (P ¼ 0.022, P ¼ 0.021 and P ¼ 0.011 at 24, 48 and 72 h, respectively) and recovery of CD34 þ /7AAD-cells (P ¼ 0.001 and Po0.001 after 48 and 72 h, respectively) were significantly decreased compared to 4 1C storage (Figures 6b and c) . Both bacteria proliferated dramatically at RT, but not at 4 1C (Figures 5d-f and 6d-f) , as demonstrated by all three detection methods, so that bacterial growth markedly outpaced any bacterial phagocytosis which might concurrently have taken place. Significant differences between cold-and RT-stored samples were observed by BacT/ Alert (Po0.001 for all time points for both bacteria), by agar plate enumeration (S. aureus: P ¼ 0.042, P ¼ 0.021 and Po0.001 after 24, 48 and 72 h, respectively, K. pneumoniae: P ¼ 0.005, Po0.001 at 48 and 72 h, respectively); and by Bactiflow (S. aureus: P ¼ 0.003 and Po0.001 after 48 and 72 h, respectively, K. pneumoniae: P ¼ 0.002 and Po0.001 after 48 and 72 h, respectively). At 4 1C, no bacterial proliferation was observed (Figures 5d-f and 6d-f ) and haematological product quality remained unaltered compared to sterile BM samples (Figures 5a-c and 6a-c) .
When lower numbers of CFU (1 CFU/mL) were inoculated onto BM samples for S. epidermidis (N ¼ 5 independent samples) and E. coli (N ¼ 7 independent samples), in 5/5 or 6/7 of the samples stored at room temperature and in 3/5 or 6/7 samples incubated at 4 1C with S. epidermidis or E. coli, respectively, bacteria could no longer be detected at the 72 h time point (sterile by all three methods) (Figures 7d,e and 8d,e) . Bacterial identification, performed on positive BacT/Alert bottles, recovered the spiked agent in all but three BacT/Alert false-positive cases (3 false positives out of 4700 total BacT/Alert analyses). Hematopoietic quality was well preserved in all samples irrespective of storage temperature.
DISCUSSION
Since currently approximately 1/3 of all BM products cross international borders and specifically, more than 400 BM transplants travel between Europe and the US every year, 32 studies analyzing under which conditions the quality of BM Hematopoietic Quality of BM and storage temperature S Hahn et al transplants is best maintained remain relevant. The NMDP recommends BM transplantation within 24 h of the harvest. 33 The recommendation is supported by a number of studies, including this one, which unanimously agree that product quality begins to deteriorate from the moment the marrow is harvested. The relevance of this observation is demonstrated by studies of Lazarus et al. 34 which report that a delay of X20 h from collection is already associated with inferior transplant outcomes. Such studies underscore the importance of immediate product pick-up from the collection site and of minimizing the holding time in the transplant center. While the time frame may be challenging for BM transplants travelling between Europe and transplant centers in Australia or New Zealand, transplants travelling between Europe and North America can meet this deadline, provided adequate organizational steps are taken in the transplant center.
Our data indicate that for the entire shelf life of fresh BM, that is, 72 h, the hematopoietic quality of sterile BM samples as well as of samples contaminated with typical agents like P. acnes and S. epidermidis is best maintained when stored at RT, even though the advantage is quantitatively modest. Moreover, at 4 1C the fat in BM aspirates solidifies, so that BM products must be allowed to equilibrate to RT before they can be administered. This necessarily delays their administration by another several hours, with predictable adverse effects on their hematopoietic quality. Importantly, functional assays of BM products (clonogenic assays) demonstrate markedly lower recovery rates compared to phenotypic analyses, indicating that FACS enumeration of 7AAD-negative 'stem cells' (according to ISHAGE gating) markedly overestimates the content of functional hematopoietic stem/ progenitor cells, in agreement with earlier reports. [35] [36] [37] Surprisingly few and relatively small systematic studies have previously been reported about BM product quality (by phenotypic or functional in vitro assays) over time under different storage temperatures. [36] [37] [38] Lasky et al. 39 analyzed the clonogenicity of 5 marrow samples. BM was collected into Heparin-substituted minimal essential medium with Hank's balanced salt solution, which is not an approved supplement for clinical BM products, and stored in Teflon-coated non-breathable plastic bags, to create a 'worst-case milieu'. CFU-C recovery deteriorated over time under both storage conditions. Quality appeared to be better preserved at 4 1C than at 22 1C but statistical analyses were not performed. Antonenas et al. 38 report data from a total of 12 BM samples, 4 autologous and 8 allogeneic, which were kept in sterile tubes stored at 2-8 1C or 18-24 1C for Quality of BM and storage temperature S Hahn et al up to 72 h. Anti-coagulant and carrier solution, if any, are not mentioned. Recovery of 'viable' CD34 þ cells over time, in agreement with our data, deteriorated in a linear fashion without a discernible effect of storage temperature. However, clonogenic assays, where in our experiments a small difference between 4 1C and RT storage became visible, were not performed; definitive conclusions are therefore not possible. More recently, Kao and colleagues 36 collected five 40-mL BM samples into 3.5 mL Ringer's solution with 300 iU of Heparin specifically for the purpose of evaluating effects of storage temperature. The analyzed samples were characterized by untypically low WBC of only 14 G/mL, which is only about half the cellularity of the marrows included in our study. As in the Lasky study, 39 Kao et al. used not oxygenpermeable transfer bags. It is proposed that such storage conditions may put cells that are RT-stored and thus metabolically more active at a disadvantage. Licensed BM storage bags, however, are oxygen-permeable, which we attempted to mimic with our storage conditions in uncapped tubes. In the Kao study, the recovery of viable CD34 þ cells and CFU-C was not differentially affected by storage temperature. Interestingly, the authors demonstrate a survival advantage of PBSC samples containing ACD-A. The effect was suggested to be due to the ability of ACD-A to stabilize pH and/or limit lactic acid generation. Although this permutation was not tested for BM aspirates, the fact that all our BM samples contained ACD-A may have contributed to the modestly superior product quality at RT in our study, that is, under conditions during which leukocytes are metabolically active. A fourth study by Fry et al. 37 was recently published with 10 BM samples anti-coagulated with heparin. Recovery of WBC, 7AAD-CD34 þ cells and CFU-C was analyzed after storage at 4-8 1C vs 29-22 1C; a steady decrease in hematopoietic quality was observed without an apparent grace period as in all other studies, but differential effects of storage temperature were not noted.
As BM collection is an inherently non-sterile process, in defining the ideal storage and/or transport temperature for BM transplants, we suggest that yet another permutation, that is, bacterial safety and possible effects of bacterial growth on hematopoietic quality vs autosterilization should also be considered. For 2012, the NMDP reports an incidence of bacterial contamination of 10.1% in a total of 1158 BM products (personal communication to HB), similar to the incidence in our collection center (10.5%). In agreement with these data, contamination rates of allogeneic BM grafts of up to 17.5% at the time of harvest have been published in several Figure 6 . Effect of storage temperature on K. pneumoniae-(100 CFU/mL) spiked BM samples with respect to haematological quality and bioburden: Hematological quality (a-c) and bioburden (d-f ) are depicted. Asterisks indicate significant differences (Student's t-test Po0.05) between RT-and cold-stored samples in SA as well as in SN BacT/Alert bottles (N ¼ 7).
Quality of BM and storage temperature S Hahn et al smaller series. 9, 14, 16, 17, [40] [41] [42] [43] To our knowledge, systematic studies with bacterially contaminated BM, including studies of the effect of bacterial contamination on hematopoietic quality, have not previously been performed. We here therefore present definitive analyses from spiking experiments with skin commensals (P. acnes, S. epidermidis), relevant in the sense that they are most commonly observed as contaminants of BM transplants, 10, 18 but typically clinically non-pathogenic for immunocompetent persons. Furthermore, the effects of three fast-growing, exo-or endotoxin-producing pathogens, that is, E. coli, S. aureus and K. pneumoniae were tested. Whereas the occasional detection of skin commensals is inherent to the trans-cutaneous access in a thick-skinned body region, the observation of any of the second group of contaminants would be indicative of insufficient skin disinfection. Indeed, as per our own experience and in agreement with published data about BM contaminants, such infectious agents have never been detected.
For contaminated platelet concentrates, a bacterial concentration of 0.03-10 CFU/mL has been reported. [44] [45] [46] The actual number of bacteria in non-sterile BM products has never been formally ascertained but, because of the inability to perform a pre-donation sampling like with standard blood products, may lie 10-100 orders of magnitude higher than in these. 46 Provided that proper aseptic technique has been applied, the source of bacteria is presumably residents from deeper skin layers and hair follicles which are protected against antibacterial effects of skin disinfection. The bacterial content of a hair follicle, approximately 10% of which are colonized, has been estimated at 2.6 Â 10E5 propionibacteria or 55.5 Â 10E3 staphylococci. 47 Assuming the complete content of one colonized hair follicle was collected during harvest of 500 or 1500 mL BM products, then bioburdens of 520 or 170 propionibacteria/mL or 11 or 4 staphylococci/mL, respectively, would be contained in the final product. The spiking dose of 100 CFU/mL used in most of our experiments was thus reasonably within the range of the expected amount of contaminating bacteria in non-sterile BM products. Equally importantly, however, this dose enables us to identify quantitative changes in bacterial contamination in both directions, that is, an increase as well as a decrease, while mitigating against the inherent risk of a sampling error associated with very low bacterial concentrations. [48] [49] [50] Logarithmic expansion of S. aureus and K. pneumoniae in RT-stored BM samples, compared with quantitatively unchanged bacterial burden in 4 1C stored BM, was not unexpected, given their mesophilic nature. [51] [52] [53] Similar growth kinetics of these Quality of BM and storage temperature S Hahn et al species have already been observed in spiking experiments with whole blood and platelet concentrates. 44, 54, 55 In the presence of high concentrations of S. aureus and K. pneumoniae (i.e. after marked bacterial proliferation has taken place), the hematopoietic quality of BM cell suspensions suffered significantly, as indicated by a loss of 60-80% of the initial clonogenic potential. In fact, a BM product contaminated to such a degree is readily recognizable during flow cytometric quality control in the receiving transplant center. In such a case, it will be reasonable to withhold the BM graft and to request a second collection immediately, instead of relying on concurrent antibiotic treatment. The exceedingly improbable, yet dramatic outcome for RT-stored BM contaminated with highly proliferative pathogenic strains should be balanced against the overall evidence that the hematopoietic quality of uncontaminated BM is maintained better at RT, as well as in the presence of most bacteria, notably including E. coli, RT-stored BM was at least equal in hematopoietic quality. Surprisingly, the average maintenance of hematopoietic quality in E. coli spiked samples, irrespective of storage temperature, seemed to be slightly (but not significantly) better than in all others, including in unspiked samples. Beneficial effects of LPS-producing bacteria on hematopoietic cell maintenance could theoretically be explained by activation of monocytes eliciting hematopoietic growth factors, but then the effect should likely have been limited to, or more pronounced in, RT-stored samples. Therefore, the most likely explanation for the observation is that some exceptionally fit BM samples were, by chance, selected for E. coli-spiking experiments.
The reduction of bacteria to below the level of detection in some experiments is likely due to phagocytosis by leukocytes. Auto-sterilization of whole blood products has been appreciated for more than 50 years 56 and has led to the requirement that whole blood donations must be stored at RT for several hours prior to refrigeration or component separation. [57] [58] [59] Evidence of auto-sterilizing capacity of BM has been provided previously. Thus bactericidal effects of BM against S. epidermidis are most pronounced during the first 24 h of storage. 16 Similar to platelet concentrates, BM provides bacteria with a nutrient-rich environment which may allow differential bacterial growth depending on strain-/stem-specific metabolic properties and donor properties; at the same time, the capacity for autophagocytosis may vary between donors. 46 This likely explains the differential bacterial growth observed in our spiking experiments with E. coli, ranging from uninhibited proliferation to autosterilization at RT. The clinical significance of contaminated stem cell grafts per se appears to be very low. A number of groups have neither recovered the isolated bacterial species in post-transplantation blood cultures of patients 11, 12, 14, 16, 19, 42 nor did they find any clinically significant differences in patient outcomes compared to recipients of sterile stem cell products. 9, 16, 43, 60 As much as the occurrence of infectious adverse events depends on the immune status of the recipient, currently used prophylactic antibiotic treatment of all patients undergoing SCT may contribute to this. According to an extensive literature search, only two cases of sepsis after infusion of contaminated allogeneic BM products, both involving Bacillus cereus and neither fatal, have been documented in the entire history of SCT. 12, [61] [62] [63] However, a number of cases of bacterial sepsis caused by contaminated standard blood products, including several with fatal outcome, have been reported, importantly both for platelet concentrates, which are stored at RT, and for erythrocyte concentrates, which are stored at 4 1C. [64] [65] [66] Considering that only approximately 3000 BM transplantations are performed per year world-wide, compared to use of more than 5 million conventional blood products per year in Germany alone, the possibility that the apparent safety of contaminated BM products is simply a phenomenon of small numbers cannot be excluded.
The global collaboration of the transplant community, with transplants travelling between countries and continents, has spurred attempts at international standardization, including recommendations for uniform storage and transport temperatures of stem cell products. Recommendations based solely on phenotypic analysis of samples, 38 without considering functional properties of stem/progenitor cells and biological safety, may fall short in scope. Ease of maintaining 4 1C vs RT has sometimes been mentioned as a reason to prefer cold transportation. While it is indeed difficult to maintain RT over extended periods by use of insulated transportation boxes alone, the challenge has been largely overcome since the advent of active thermo elements for most temperature ranges including 'room temperature'.
In summary, we confirm, using modern techniques, that the hematopoietic quality of sterile BM aspirates is well maintained at RT during the entire shelf life of a BM product. Typical skin commensals demonstrate a reduced proliferation rate or are even killed during RT storage, and their presence does not affect hematopoietic quality. E. coli were killed in our experiments during RT storage in all but one sample containing low concentrations of bacteria as well as killed or arrested in 80% of samples with a high bacterial burden. This provides evidence for a considerable capacity of BM for auto-sterilization which is variable in potency and, not surprisingly, more acute at RT than in the cold. Thus for all BM products observed in our practice, that is, sterile BMs, which represent the vast majority (ca. 90%) of BMs, and the occasional BM contaminated with P. acnes (in our hands ca. 6%), S. epidermidis (ca. 3%) and other skin commensals (in our clinical cohort ca. 1%), RT storage will best (although by a small margin) support hematopoietic quality without jeopardizing microbial safety, and hence, our data support current recommendations by ZKRD and NMDP suggesting RT transportation and storage of BM. The linear decrease in product quality over time, without any apparent grace period during which the product quality remains stable, firmly underscores the necessity for expedited transportation and immediate transfusion of BM products at the receiving hospital.
